The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(5-(carbamimidoylcarbamoyl)-2-(2-(4-(2,3,4-trimethoxybenzyl)piperazin-1-yl)ethoxy)phenyl)-3-methylthiophene-2-carboxamide ID: ALA1829127
PubChem CID: 54770223
Max Phase: Preclinical
Molecular Formula: C30H38N6O6S
Molecular Weight: 610.74
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(CN2CCN(CCOc3ccc(C(=O)NC(=N)N)cc3NC(=O)c3sccc3C)CC2)c(OC)c1OC
Standard InChI: InChI=1S/C30H38N6O6S/c1-19-9-16-43-27(19)29(38)33-22-17-20(28(37)34-30(31)32)5-7-23(22)42-15-14-35-10-12-36(13-11-35)18-21-6-8-24(39-2)26(41-4)25(21)40-3/h5-9,16-17H,10-15,18H2,1-4H3,(H,33,38)(H4,31,32,34,37)
Standard InChI Key: PKBMYKOFRVDWAP-UHFFFAOYSA-N
Molfile:
RDKit 2D
43 46 0 0 0 0 0 0 0 0999 V2000
3.7152 -18.3166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7141 -19.1440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4289 -19.5569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1453 -19.1435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1425 -18.3130 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4271 -17.9039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4246 -17.0789 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1379 -16.6642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0007 -17.9043 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.0005 -17.0793 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9993 -19.5559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2851 -19.1429 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8554 -17.8978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5714 -18.3076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5719 -19.1298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2838 -19.5395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9992 -19.1278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9980 -18.3019 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2816 -17.8876 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7136 -19.5404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4281 -19.1279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1426 -19.5404 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.8571 -19.1279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5692 -19.5408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2832 -19.1290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2837 -18.3031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5642 -17.8908 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8531 -18.3049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1314 -17.8939 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9976 -17.8897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7126 -18.3012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9965 -17.0647 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4265 -17.8878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1415 -18.2993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4254 -17.0628 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.1265 -17.0689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8386 -16.6522 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.4094 -16.6607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4112 -15.8354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6281 -15.5761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1394 -16.2408 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6205 -16.9110 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
10.0806 -15.3531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20 21 1 0
2 3 1 0
21 22 1 0
2 11 1 0
22 23 1 0
5 6 2 0
23 24 2 0
11 12 1 0
24 25 1 0
6 1 1 0
25 26 2 0
5 13 1 0
26 27 1 0
1 2 2 0
27 28 2 0
28 23 1 0
13 14 1 0
28 29 1 0
14 15 1 0
26 30 1 0
6 7 1 0
30 31 1 0
3 4 2 0
30 32 2 0
7 8 1 0
31 33 1 0
33 34 1 0
1 9 1 0
33 35 2 0
14 19 1 0
29 36 1 0
15 16 1 0
36 37 2 0
16 17 1 0
36 38 1 0
41 42 1 0
17 18 1 0
39 40 1 0
18 19 1 0
4 5 1 0
17 20 1 0
38 39 2 0
40 41 2 0
42 38 1 0
9 10 1 0
39 43 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 610.74Molecular Weight (Monoisotopic): 610.2574AlogP: 3.15#Rotatable Bonds: 12Polar Surface Area: 151.47Molecular Species: NEUTRALHBA: 10HBD: 4#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 12.72CX Basic pKa: 7.17CX LogP: 3.03CX LogD: 2.81Aromatic Rings: 3Heavy Atoms: 43QED Weighted: 0.18Np Likeness Score: -1.39
References 1. Jin L, Jiang XM, Du P, Xu J, Gong GQ, Wang QJ, Xu YG.. (2011) Synthesis and Na+/H+ exchanger inhibitory activity of benzoylguanidine derivatives., 46 (9): [PMID:21724305 ] [10.1016/j.ejmech.2011.06.011 ]